Ignite Planners, LLC Veru Inc. Transaction History

Ignite Planners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	SELL	$0.98 - $1.49 $392 - $596	-400 Reduced 0.79%	50,300 $59,000
Q4 2022 Feb 02, 2023	BUY	$4.78 - $15.01 $1,912 - $6,004	400 Added 0.8%	50,700 $267,000
Q3 2022 Oct 12, 2022	BUY	$10.22 - $23.7 $9,453 - $21,922	925 Added 1.87%	50,300 $618,000
Q2 2022 Jul 15, 2022	BUY	$4.35 - $15.85 $15,224 - $55,475	3,500 Added 7.63%	49,375 $665,000
Q1 2022 May 13, 2022	BUY	$4.55 - $6.41 $13,650 - $19,230	3,000 Added 7.0%	45,875 $514,000
Q4 2021 Feb 02, 2022	BUY	$5.89 - $9.73 $252,533 - $417,173	42,875 New	42,875 $243,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Ignite Planners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ignite Planners, LLC with notifications on news.